You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LR-MDS

Showing 1 - 25 of 1,145
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lower-risk Myelodysplastic Syndrome Trial in Tampa (JSP191)

Recruiting
  • Lower-risk Myelodysplastic Syndrome
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2023

Low Risk MDS Trial (R906289 Monosodium (R289 Na))

Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
Jul 22, 2022

Preleukemia, MDS, Cytopenia Trial in Copenhagen (Metformin)

Recruiting
  • Preleukemia
  • +2 more
  • Copenhagen, Copenhagen N, Denmark
    Rigshospitalet
Jan 20, 2022

MDS Trial (AG-946, Placebo)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Aug 4, 2022

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

Anemia, MDS Trial in Germany (Canakinumab Injection)

Recruiting
  • Anemia
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Berlin, Germany
  • +5 more
Nov 8, 2022

MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • Luspatercept Injection [Reblozyl]
  • Eprex
  • Amiens, France
  • +30 more
May 19, 2022

MDS, Anemia Trial in Germany (Luspatercept Injection)

Recruiting
  • Myelodysplastic Syndromes
  • Anemia
  • Luspatercept Injection
  • Berlin, Germany
  • +18 more
Jan 25, 2023

MDS Trial in Worldwide (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Los Alamitos, California
  • +53 more
Sep 13, 2023

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

MDS Trial in Beijing (Roxadustat, Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 17, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Interplay Between Immune and Metabolic Programs in

Recruiting
  • Myelodysplastic Syndromes
    • Toulouse, France
      IUCT-Oncopole University Hospital
    May 17, 2022

    MDS Trial in Japan (Eltrombopag, Placebo)

    Recruiting
    • Myelodysplastic Syndromes
    • Narita, Chiba, Japan
    • +21 more
    Jan 19, 2023

    Myeloid Diseases Trial (DFV890)

    Not yet recruiting
    • Myeloid Diseases
    • (no location specified)
    Nov 11, 2022

    Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

    Terminated
    • Myelodysplastic Syndrome
    • +3 more
    • La Jolla, California
    • +157 more
    Sep 22, 2022

    AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

    Recruiting
    • AML
    • +3 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 27, 2021

    Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))

    Not yet recruiting
    • Genetic Predisposition
    • Next-Generation Sequencing (NGS)
    • Tübingen, Germany
      University Hospital Tübingen
    Sep 22, 2023

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

    Active, not recruiting
    • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
    • +9 more
    • Sewell, New Jersey
    • +4 more
    Dec 13, 2022

    MDS Trial in France, Germany, United States (Oral rigosertib)

    Completed
    • Myelodysplastic Syndromes
    • Oral rigosertib
    • Stanford, California
    • +13 more
    Jun 15, 2021

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

    Completed
    • Myelodysplastic Syndrome
    • +2 more
    • Gilbert, Arizona
    • +12 more
    Jun 15, 2021

    EVOKE ECAP-Controlled Lead Placement and Programming in Chronic

    Not yet recruiting
    • Back Pain Lower Back Chronic
    • Spinal Cord Stimulation
    • spinal cord stimulation
    • London, United Kingdom
      Barts Health NHS Trust
    Jan 25, 2023

    Complex Atypical Hyperplasia, Endometrial Cancer Trial in Chapel Hill, Cincinnati (Metformin)

    Recruiting
    • Complex Atypical Hyperplasia
    • Endometrial Cancer
    • Chapel Hill, North Carolina
    • +1 more
    Jan 18, 2023

    Burn Injury Trial in Canada, United States (Albumin Human)

    Recruiting
    • Burn Injury
    • Albumin Human
    • Phoenix, Arizona
    • +25 more
    Aug 9, 2022